Geraldine Cayanan brings a wealth of scientific and research experience to her role at Blue Matter, with a particular focus in molecular oncology. She has been a member of the Blue Matter team since 2022 and also has consulting experience from LifeSci Partners. Her industry experience includes time at Nimbus Therapeutics and Protara Therapeutics. Geraldine’s research background includes oncology-focused work at UCSF and at the NYU Grossman School of Medicine. Geraldine earned a PhD in Molecular Oncology from the NYU Grossman School of Medicine and a BS in Biological Sciences from UC Davis.